Catching them before injection is always better than troubleshooting afterward
For 503A pharmacies, FDA reiterated a limited enforcement policy from its 2018 guidance, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: the agency does not intend to take action where a compounder fills four or fewer prescriptions per calendar month of a drug that is essentially a copy of a commercially available drug
(2016) Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity Ryan, Donna H., Ryan Yockey, Sarah (2018) Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over Brown, Joshua D., et al (2015) Effects on cardiovascular risk factors of weight losses limited to 510% Georgoulis, Michael, et al
For a Medicare beneficiary who is diabetic, obese, and living on a fixed income, the deal could mean the availability of proven GLP-1s without breaking the bank